Real-Life Efficacy of Palbociclib and Ribociclib in Advanced Breast Cancer
<b>Background:</b> Clinical trials in metastatic hormone receptor-positive (HR+) human epidermal growth factor receptor-2 (HER2)-negative patients have shown that cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors both increase response rates and provide survival benefits. The efficacy of these therap...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2025-03-01
|
| Col·lecció: | Current Oncology |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/1718-7729/32/3/161 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|